General Announcement::Mesoblast and Lonza Enter into Agreement for Commercial Manufacture of Mesoblast's Remestemcel-L
Original SGX announcement
Read the archived filing
Membership includes the on-site filing reader and available attachments.
SGD 5 / month
Billed automatically. Cancel any time.
Sign in to subscribeWhat membership includes
- Full recorded dividend history
- Archived SGX filing details and available attachments
- Ad-free browsing